Nir Barzilai, MD, is the founding director of the Institute for Aging Research at the Albert Einstein College of Medicine, and the director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health's Nathan Shock Centers. He also discovered the first longevity gene in humans.
Dr. Barziali joined Dr. Amir Hadanny, Dr. Eric Verdin, Dr. Michael Roizen and Dr. Joseph Maroon for the 2024 Global Aging Consortium Longevity Summit in The Villages, FL.
Dr. Barzilai discusses The SuperAgers Initiative, a study of centenarians and their families. He also reveals the hallmarks and biomarkers of aging, the future for anti-aging drugs (such as metformin), and the difference between healthspan and lifespan.
Learn more about the secrets of super agers, hyperbaric oxygen therapy, the biology of aging, and gerotherapeutics.
You can view and download the presentation slides here: www.avivprotocol.com/2024_Lon....
Contact us to learn more about the personalized Aviv Medical Program. For more information and to determine if you are a candidate for the Aviv Medical Program, contact Aviv Clinics today at aviv-clinics.com/contact-us or call 352-492-6602 to speak with a Client Ambassador.
Learn about the science behind hyperbaric oxygen therapy: aviv-clinics.com/hyperbaric-t...
Subscribe to our channel:
/ @avivclinics
Follow us to stay updated on all things Aviv Clinics!
Facebook: / avivclinics
Instagram: / avivclinics
LinkedIn: / avivclinics